Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ndonovo Therapeutics Inc (ENDV)

Ndonovo Therapeutics Inc (ENDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ndonovo Therapeutics Inc 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 USA

www.endonovo.com P: 800-701-1223

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Endonovo Therapeutics, Inc. is a biotechnology company which is engaged in developing a bioelectronic approach to regenerative medicine. The company's Immunotronics(TM) platform is a non-invasive, non-implantable bioelectronic device for treating/preventing vital organ failure through the reduction of inflammation and necrosis, and the promotion of regeneration. Endonovo's Cytotronics(TM) platform provides method of expanding and manipulating cells using simulated microgravity and Time-Varying Electromagnetic Fields for tissue engineering and cell therapies. Endonovo Therapeutics, Inc. is headquartered in Woodland Hills, California.

Key Statistics

Overview:

Market Capitalization, $K 145
Enterprise Value, $K 145
Shares Outstanding, K 1,445,713
Float, K 1,364,609
% Float 94.39%
Short Volume Ratio 1.00
% of Insider Shareholders 5.61%
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 10 K
Annual Net Income, $ -2,800 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -540 K
EBIT, $ 0 K
EBITDA, $ -2,230 K

Growth:

1-Year Return -50.00%
3-Year Return -99.36%
5-Year Return -99.77%
5-Year Revenue Growth -96.77%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.00 on 11/14/25
Next Earnings Date 03/20/26 [--]
Earnings Per Share ttm 0.00
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-1000 on 12/20/19

ENDV Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -28,000.00%
Debt/Equity 0.00
Price/Sales 14.50
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.08
Interest Coverage 0.00
60-Month Beta -1.20
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar